These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3429683)

  • 1. Blood pressure monitoring for assessing the duration of action of antihypertensive treatment.
    Weber MA; Tonkon MJ; Klein RC
    J Clin Pharmacol; 1987 Oct; 27(10):751-5. PubMed ID: 3429683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
    Cheung DG; Gasster JL; Weber MA
    Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G
    Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prazosin once or twice daily?
    Westerman RF; Schouten JA; Hengeveld WL
    Eur J Clin Pharmacol; 1985; 28(1):11-5. PubMed ID: 3987782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild hypertension in the elderly. A comparison of prazosin and enalapril.
    Cheung DG; Hoffman CA; Ricci ST; Weber MA
    Am J Med; 1989 Jan; 86(1B):87-90. PubMed ID: 2536516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prazosin versus propranolol plus prazosin: a comparison in diuretic-treated hypertensive patients.
    Kochar MS; Kalbfleisch JH; Blumenthal SS; Maierhofer WJ
    Am J Cardiol; 1984 Jan; 53(3):55A-58A. PubMed ID: 6695766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trials of terazosin with other antihypertensive agents.
    Ruoff G
    Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin alone and combined with a beta-adrenoreceptor blocker in treatment of hypertension.
    Gould BA; Hornung RS; Kieso HA; Cashman PM; Raftery EB
    J Cardiovasc Pharmacol; 1983; 5(4):678-84. PubMed ID: 6193367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosin.
    Weber MA; Cheung DG; Laddu AR; Luther RR
    Am Heart J; 1991 Sep; 122(3 Pt 2):905-10. PubMed ID: 1678921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA; Byyny RL; Pratt JH; Faison EP; Snavely DB; Goldberg AI; Nelson EB
    Arch Intern Med; 1995 Feb; 155(4):405-11. PubMed ID: 7848024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of labetalol and prazosin in hypertensive patients using automated ambulatory monitoring.
    Gray JM; Silberman HM; Gorwit JI
    Am J Med; 1988 May; 84(5):904-10. PubMed ID: 3284341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour period.
    Miyoshi K; Okura T; Nagao T; Masanori J; Irita J; Higaki J
    Clin Ther; 2013 Sep; 35(9):1418-22. PubMed ID: 23972579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraindividual comparison of moxonidine and prazosin in hypertensive patients.
    Plänitz V
    Eur J Clin Pharmacol; 1986; 29(6):645-50. PubMed ID: 3709608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antihypertensive therapy on the circadian blood pressure pattern.
    Weber MA; Tonkon MJ; Klein RC
    Am J Med; 1987 Jan; 82(1A):50-2. PubMed ID: 3799701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
    Giannattasio C; Cattaneo BM; Seravalle G; Carugo S; Mangoni AA; Grassi G; Zanchetti A; Mancia G
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S18-22. PubMed ID: 1378144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.